Purchases are not available yet. You can browse the site and sign in.
South Africa Psilocybin Court Ruling 2024 Explained · Microdosing College
Law
South Africa's 2024 High Court Psilocybin Ruling: What 'Unconstitutional' Actually Changed
By Microdosing College Editorial·Last updated June 6, 2026·7 min read
The south africa psilocybin court ruling in brief
On 24 April 2024 the Gauteng Division of the High Court of South Africa handed down a landmark judgment in Cromhout and Others v Minister of Justice and Correctional Services and Others. The court declared that provisions of the Drugs and Drug Trafficking Act 140 of 1992 and the Medicines and Related Substances Act 101 of 1965 — insofar as they criminalised private adult possession and cultivation of psilocybin and psilocin — were inconsistent with the Constitution of the Republic of South Africa and therefore invalid.
The ruling did not legalise psilocybin in any commercial sense. It carved out a narrow constitutional protection for private, adult, personal use — mirroring a legal trajectory already established in South African case law around cannabis. Understanding what the court actually said, and what it did not say, matters enormously before drawing any conclusions about what is now permitted. For a broader international overview, see our guide to .
The applicants in Cromhout argued that the blanket criminalisation of psilocybin possession and cultivation — even in private, by adults, for personal use — violated Section 14 of the Constitution, which protects the right to privacy. The court agreed.
Judge Sarah Kathleen Sarah delivered the judgment, ruling that the right to privacy extends to what adults choose to consume in private, and that the state had not demonstrated a sufficiently compelling justification to override that right in the context of personal possession and home cultivation. The court was explicit that its finding applied only to private, adult, personal use — it made no finding about commercial supply, public use, or access routes.
Critically, the declaration of invalidity was suspended for 24 months from the date of the judgment. This is standard constitutional practice in South Africa: a suspended order preserves the existing legislative framework while giving Parliament time to cure the defect. During the suspension period the criminal provisions remain technically operative. The court did not direct that prosecutions cease immediately, though the practical effect of an unconstitutionality finding creates a powerful defence for individuals charged with private possession during the suspension.
The judgment papers were published by Schindlers Attorneys, the legal firm that brought the case (see Sources below). Their case overview confirms that psilocybin and psilocin remain on Schedule 7 of the Medicines Act — the most restrictive scheduling level in South Africa — which has implications for everything outside the narrow private-use window.
What remains illegal — and why that matters
The ruling's scope is precise and limited. The following activities were not affected by the court's finding and remain criminal offences under South African law:
Buying or selling psilocybin or psilocybin-containing products
Supplying psilocybin to any other person, even without payment
Importing or exporting psilocybin
Public possession or use
Any possession or cultivation by minors
The Schedule 7 listing under the Medicines Act also means that no healthcare provider may lawfully prescribe psilocybin in South Africa under existing regulations. Unlike the United States (where some states have opened therapeutic pathways) or Australia (which established a prescriber scheme), South Africa has no clinical access route as of mid-2026. For comparison, see our article on the decriminalization vs. legalisation distinction.
This gap matters for anyone reading the ruling optimistically: even if private possession creates a constitutional defence, the only way to obtain psilocybin remains through channels that are unambiguously illegal. The ruling protects the private act of possession; it provides no legal pathway to acquire the substance.
The 24-month parliamentary window
The suspension of the invalidity declaration expires in April 2026 — which means Parliament had until that date to amend the Drugs Act and the Medicines Act to bring them into constitutional compliance. As of the date of this article's publication, no amending legislation had been signed into law.
Several outcomes are possible if Parliament does not act before the deadline:
The declaration takes full effect, meaning the criminal provisions fall away for private adult possession and cultivation and prosecutors lose the statutory basis to charge.
Parliament passes interim or transitional legislation, possibly creating a regulated personal-use exemption modelled on the cannabis precedent.
The government seeks a further suspension or appeal to the Constitutional Court.
The South African Law Reform Commission has been studying drug-policy reform for several years, and the cannabis decriminalisation experience — which followed a similar Constitutional Court trajectory in Minister of Justice and Constitutional Development v Prince (2018) — offers the most likely template for how psilocybin reform would be structured.
For context on why psilocybin has been prohibited almost everywhere in the first place, our article on why psilocybin is banned in most countries traces the 1971 UN Convention on Psychotropic Substances and how it shaped national scheduling decisions, including South Africa's.
Practical implications for individuals in South Africa
For adults in South Africa considering what the ruling means in practice, several points deserve careful attention.
A constitutional defence is not immunity. During the suspension period, the existing criminal provisions remained on the books. Someone arrested for private possession would need to actively raise the constitutional defence in court — they would not automatically be immune from arrest, charge, or prosecution.
There is no legal supply chain. Even if private possession becomes fully decriminalised after the suspension lapses, obtaining psilocybin through purchase or receipt from another person remains a criminal act. This is a structural gap the ruling does not resolve.
Medical and therapeutic use is not authorised. The ruling was not a clinical ruling. It has no bearing on the Schedule 7 status under the Medicines Act for prescribing purposes. Anyone in South Africa seeking psilocybin for mental health purposes should consult a qualified healthcare provider about legal options, which currently do not include psilocybin-assisted therapy within the South African system.
The ruling applies in South Africa only. For travellers and international readers, this judgment has no legal force outside South African jurisdiction. Each country's laws apply to that country's territory. Our microdosing laws by country pillar covers the global picture.
If you are uncertain whether any substance use is appropriate for your personal health situation, we recommend using the self-screener as a starting point before making any decisions.
Where South Africa sits in the global reform landscape
The Cromhout ruling places South Africa in a small but growing group of jurisdictions where courts or legislatures have begun to distinguish between private adult use and commercial distribution of psychedelics. The trajectory closely mirrors the cannabis path in South Africa itself, and echoes constitutional reasoning seen in some Latin American courts.
It does not place South Africa in the same category as jurisdictions with active therapeutic access — such as Australia's prescriber scheme or Oregon's regulated service centres — because those frameworks addressed clinical supply, whereas Cromhout addressed only personal possession. The distinction between decriminalisation and legalisation is not merely semantic; it determines whether supply chains can operate lawfully.
The next meaningful legal milestone will be what Parliament does — or does not do — with the 24-month window. Advocacy organisations, legal practitioners, and researchers in South Africa are closely watching both the legislative calendar and any indication of appeal. Until that picture clarifies, the legal status of psilocybin in South Africa remains genuinely uncertain: constitutionally contested in private possession, prohibited in every commercial dimension.
Frequently asked
What did the South African High Court rule about psilocybin in 2024?+
In Cromhout and Others v Minister of Justice (April 2024), the Gauteng High Court declared that criminalising private adult possession and cultivation of psilocybin was inconsistent with the constitutional right to privacy. The declaration of invalidity was suspended for 24 months to allow Parliament to amend the law.
Is psilocybin now legal to buy or sell in South Africa?+
No. The ruling was limited to private adult possession and home cultivation. Buying, selling, supplying, importing, and exporting psilocybin remain criminal offences under the Drugs and Drug Trafficking Act 140 of 1992 and the Medicines Act 101 of 1965.
Can a South African doctor prescribe psilocybin after the ruling?+
No. The court's finding did not affect psilocybin's Schedule 7 listing under the Medicines Act, which is the most restrictive scheduling level. No legal prescribing or clinical supply route exists in South Africa as of mid-2026.
What happens if Parliament does not amend the law within 24 months?+
If Parliament does not act before the suspension lapses (April 2026), the criminal provisions would fall away for private adult possession and cultivation, because the court found them constitutionally invalid. The government could also seek a further suspension or appeal to the Constitutional Court.
Does the ruling protect someone arrested for private psilocybin possession in South Africa?+
It provides a constitutional defence, but not automatic immunity. During the suspension period the criminal provisions technically remained operative. A person arrested during this time would need to raise the unconstitutionality finding as a defence in court proceedings.
This guide is general educational information about microdosing, not medical advice and not a recommendation to use any substance. It can't account for your personal health. If you take medication or live with a mental-health condition, speak with a qualified professional before making any decision.
